{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:41:23Z","timestamp":1791499283229,"version":"4.3.4"},"reference-count":66,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.steroids.2011.02.034","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T13:49:30Z","timestamp":1299332970000},"page":"781-785","source":"Crossref","is-referenced-by-count":18,"title":["Pharmacology of arthralgia with estrogen deprivation"],"prefix":"10.1016","volume":"76","author":[{"given":"Anneleen","family":"Lintermans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"January (9453)","key":"10.1016\/j.steroids.2011.02.034_bib0005","first-page":"60","article-title":"Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial after completion of 5 years\u2019 adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"issue":"May (15)","key":"10.1016\/j.steroids.2011.02.034_bib0010","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1200\/JCO.2006.09.4482","article-title":"Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17","volume":"25","author":"Goss","year":"2007","journal-title":"J Clin Oncol"},{"issue":"March (11)","key":"10.1016\/j.steroids.2011.02.034_bib0015","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer","volume":"350","author":"Coombes","year":"2004","journal-title":"N Engl J Med"},{"issue":"February (9561)","key":"10.1016\/j.steroids.2011.02.034_bib0020","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","article-title":"Survival and safety of exemestane versus tamoxifen after 2\u20133 years\u2019 tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial","volume":"369","author":"Coombes","year":"2007","journal-title":"Lancet"},{"issue":"December (26)","key":"10.1016\/j.steroids.2011.02.034_bib0025","first-page":"2747","article-title":"A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer","volume":"353","author":"Th\u00fcrlimann","year":"2005","journal-title":"N Engl J Med"},{"issue":"February (5)","key":"10.1016\/j.steroids.2011.02.034_bib0030","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98","volume":"25","author":"Coates","year":"2007","journal-title":"J Clin Oncol"},{"issue":"October (10)","key":"10.1016\/j.steroids.2011.02.034_bib0035","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1470-2045(07)70317-0","article-title":"Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conference","volume":"8","author":"Rabaglio","year":"2007","journal-title":"Lancet Oncol"},{"issue":"November (6)","key":"10.1016\/j.steroids.2011.02.034_bib0040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/01.cco.0000180434.31991.bf","article-title":"Choosing between an aromatase inhibitor and tamoxifen in the adjuvant setting","volume":"17","author":"Morales","year":"2005","journal-title":"Curr Opin Oncol"},{"issue":"February","key":"10.1016\/j.steroids.2011.02.034_bib0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1749-6632.2009.03688.x","article-title":"Phase 3 trials of aromatase inhibitors for breast cancer prevention: following in the path of the selective estrogen receptor modulators","volume":"1155","author":"Dunn","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"September (25)","key":"10.1016\/j.steroids.2011.02.034_bib0050","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1200\/JCO.2007.10.7573","article-title":"Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer","volume":"25","author":"Crew","year":"2007","journal-title":"J Clin Oncol"},{"issue":"September (2)","key":"10.1016\/j.steroids.2011.02.034_bib0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-007-9774-6","article-title":"Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors","volume":"111","author":"Henry","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"November (19)","key":"10.1016\/j.steroids.2011.02.034_bib0060","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer","volume":"349","author":"Goss","year":"2003","journal-title":"N Engl J Med"},{"issue":"September (25)","key":"10.1016\/j.steroids.2011.02.034_bib0065","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1200\/JCO.2009.24.9565","article-title":"Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women","volume":"28","author":"Carlson","year":"2010","journal-title":"J Clin Oncol"},{"issue":"May (10)","key":"10.1016\/j.steroids.2011.02.034_bib0070","first-page":"2767","article-title":"Aromatase inhibitors and arthralgia","volume":"19","author":"Donnellan","year":"2001","journal-title":"J Clin Oncol"},{"issue":"October (30)","key":"10.1016\/j.steroids.2011.02.034_bib0075","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1200\/JCO.2009.22.0236","article-title":"Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial","volume":"27","author":"Sestak","year":"2009","journal-title":"J Clin Oncol"},{"issue":"July (1)","key":"10.1016\/j.steroids.2011.02.034_bib0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10549-006-9394-6","article-title":"Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging","volume":"104","author":"Morales","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"August (16)","key":"10.1016\/j.steroids.2011.02.034_bib0085","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1002\/cncr.24419","article-title":"Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors","volume":"115","author":"Mao","year":"2009","journal-title":"Cancer"},{"issue":"September (1)","key":"10.1016\/j.steroids.2011.02.034_bib0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.maturitas.2010.04.009","article-title":"Menopausal arthralgia: fact or fiction","volume":"67","author":"Magliano","year":"2010","journal-title":"Maturitas"},{"issue":"February (2)","key":"10.1016\/j.steroids.2011.02.034_bib0335","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.maturitas.2010.11.013","article-title":"Management of menopausal symptoms in breast cancer patients","volume":"68","author":"Loibl","year":"2011","journal-title":"Maturitas"},{"issue":"June (3)","key":"10.1016\/j.steroids.2011.02.034_bib0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.breast.2007.01.011","article-title":"Aromatase inhibitor-associated arthralgia syndrome","volume":"16","author":"Burstein","year":"2007","journal-title":"Breast"},{"issue":"November (12)","key":"10.1016\/j.steroids.2011.02.034_bib0105","first-page":"1401","article-title":"Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management","volume":"22","author":"Henry","year":"2008","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.steroids.2011.02.034_bib0110","doi-asserted-by":"crossref","unstructured":"Lintermans A, Van Calster B, Van Hoydonck M, Pans S, Verhaeghe J, Westhovens R. Aromatase inhibitor induced loss of grip strength is body mass index dependent: hypothesis generating findings for its pathogenesis. Ann Oncol, 2011; January.","DOI":"10.1093\/annonc\/mdq699"},{"issue":"December (12)","key":"10.1016\/j.steroids.2011.02.034_bib0115","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S1470-2045(08)70259-6","article-title":"Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial","volume":"9","author":"Cuzick","year":"2008","journal-title":"Lancet Oncol"},{"issue":"S24","key":"10.1016\/j.steroids.2011.02.034_bib0120","article-title":"Treatment-emerging symptoms and the risk of breast cancer recurrence in the NCIC CTG MA.17 adjuvant aromatase inhibitor trial","volume":"69","author":"Stearns","year":"2009","journal-title":"Cancer Res"},{"issue":"September (9)","key":"10.1016\/j.steroids.2011.02.034_bib0125","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S1470-2045(08)70182-7","article-title":"Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis","volume":"9","author":"Sestak","year":"2008","journal-title":"Lancet Oncol"},{"issue":"May (1)","key":"10.1016\/j.steroids.2011.02.034_bib0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0006-8993(97)00092-9","article-title":"Involvement of spinal cord delta opiate receptors in the antinociception of gestation and its hormonal simulation","volume":"757","author":"Dawson-Basoa","year":"1997","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.steroids.2011.02.034_bib0135","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0306-4522(02)01000-X","article-title":"Sex-related differences in the distribution of opioid receptor-like 1 receptor mRNA and colocalization with estrogen receptor mRNA in neurons of the spinal trigeminal nucleus caudalis in the rat","volume":"118","author":"Flores","year":"2003","journal-title":"Neuroscience"},{"issue":"September (9)","key":"10.1016\/j.steroids.2011.02.034_bib0140","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1002\/art.21364","article-title":"Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation","volume":"52","author":"Felson","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"May (10)","key":"10.1016\/j.steroids.2011.02.034_bib0145","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1523\/JNEUROSCI.18-10-03967.1998","article-title":"Estrogen-induced alteration of mu-opioid receptor immunoreactivity in the medial preoptic nucleus and medial amygdala","volume":"18","author":"Eckersell","year":"1998","journal-title":"J Neurosci"},{"issue":"August (4)","key":"10.1016\/j.steroids.2011.02.034_bib0150","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1096-9861(20000807)423:4<549::AID-CNE1>3.0.CO;2-B","article-title":"Sex hormones and pain: a new role for brain aromatase?","volume":"423","author":"Blomqvist","year":"2000","journal-title":"J Comp Neurol"},{"issue":"January (1)","key":"10.1016\/j.steroids.2011.02.034_bib0155","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4049\/jimmunol.180.1.630","article-title":"Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes","volume":"180","author":"Cvoro","year":"2008","journal-title":"J Immunol"},{"issue":"October (30)","key":"10.1016\/j.steroids.2011.02.034_bib0160","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1200\/JCO.2008.20.5435","article-title":"Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia","volume":"27","author":"Dizdar","year":"2009","journal-title":"J Clin Oncol"},{"issue":"July (3)","key":"10.1016\/j.steroids.2011.02.034_bib0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bjc.6605768","volume":"103","author":"Henry","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.steroids.2011.02.034_bib0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1359-6349(10)70402-X","article-title":"Is arthralgia observed in patients treated with adjuvant aromatase inhibitors for breast cancer related to inflammatory rheumatism? Rheumatologic evaluation of a cohort of 36 patients","volume":"8","author":"Biver","year":"2010","journal-title":"Eur J Cancer Suppl"},{"issue":"July (19)","key":"10.1016\/j.steroids.2011.02.034_bib0175","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1200\/JCO.2007.15.4005","article-title":"Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome","volume":"26","author":"Morales","year":"2008","journal-title":"J Clin Oncol"},{"issue":"September (18)","key":"10.1016\/j.steroids.2011.02.034_bib0340","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1002\/cncr.25385","article-title":"A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography","volume":"116","author":"Henry","year":"2010","journal-title":"Cancer"},{"issue":"June (3)","key":"10.1016\/j.steroids.2011.02.034_bib0185","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1188\/10.CJON.379-382","article-title":"I feel like I am 100years old! managing arthralgias from aromatase inhibitors","volume":"14","author":"Winters","year":"2010","journal-title":"Clin J Oncol Nurs"},{"issue":"March (7)","key":"10.1016\/j.steroids.2011.02.034_bib0190","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.2009.23.4708","article-title":"Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer","volume":"28","author":"Crew","year":"2010","journal-title":"J Clin Oncol"},{"issue":"August (4)","key":"10.1016\/j.steroids.2011.02.034_bib0195","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.breast.2008.02.006","article-title":"Tolerance of adjuvant letrozole outside of clinical trials","volume":"17","author":"Fontaine","year":"2008","journal-title":"Breast"},{"issue":"February (1)","key":"10.1016\/j.steroids.2011.02.034_bib0200","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10549-009-0692-7","article-title":"Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study","volume":"120","author":"Briot","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"December (Suppl. 1)","key":"10.1016\/j.steroids.2011.02.034_bib0205","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3747\/co.2007.152","article-title":"Management of arthralgias associated with aromatase inhibitor therapy","volume":"14","author":"Thorne","year":"2007","journal-title":"Curr Oncol"},{"issue":"15S","key":"10.1016\/j.steroids.2011.02.034_bib0210","article-title":"An economic analysis of arthralgia\/myalgia (A\/M) versus recurrence in women with hormone receptor-positive (HR+) breast cancer (BC) on aromatase inhibitors (AIs)","volume":"27","author":"Hadji","year":"2009","journal-title":"J Clin Oncol"},{"issue":"August (8)","key":"10.1016\/j.steroids.2011.02.034_bib0215","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1200\/JCO.1997.15.8.2974","article-title":"Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients","volume":"15","author":"Ellison","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.steroids.2011.02.034_bib0220","first-page":"S61","article-title":"levels among patients with arthralgia: results from IBIS II breast cancer prevention study","volume":"100","author":"Singh","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"February (1)","key":"10.1016\/j.steroids.2011.02.034_bib0225","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/RHU.0b013e31816356a9","article-title":"Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D","volume":"14","author":"Warner","year":"2008","journal-title":"J Clin Rheumatol"},{"issue":"November (22)","key":"10.1016\/j.steroids.2011.02.034_bib0230","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/jnci\/djn360","article-title":"Calcium plus vitamin D supplementation and the risk of breast cancer","volume":"100","author":"Chlebowski","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"July","key":"10.1016\/j.steroids.2011.02.034_bib0235","article-title":"threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study","author":"Prieto-Alhambra","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"January (1)","key":"10.1016\/j.steroids.2011.02.034_bib0240","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10549-009-0495-x","article-title":"Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer","volume":"119","author":"Khan","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"June (3)","key":"10.1016\/j.steroids.2011.02.034_bib0245","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.breast.2010.03.031","article-title":"New views on treatment of aromatase inhibitors induced arthralgia","volume":"19","author":"Xepapadakis","year":"2010","journal-title":"Breast"},{"issue":"February (1)","key":"10.1016\/j.steroids.2011.02.034_bib0250","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3816\/CBC.2009.n.006","article-title":"Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms?","volume":"9","author":"Muslimani","year":"2009","journal-title":"Clin Breast Cancer"},{"issue":"November (11)","key":"10.1016\/j.steroids.2011.02.034_bib0255","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1093\/annonc\/mdq217","article-title":"Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST study","volume":"21","author":"Eidtmann","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.steroids.2011.02.034_bib0260","article-title":"Evaluation of testosterone supplementation during anastrozole therapy in a breast tumor explant model","author":"Jankovic-Karasoulos","year":"2009","journal-title":"San Antonio Breast Cancer Symp"},{"issue":"May (3)","key":"10.1016\/j.steroids.2011.02.034_bib0265","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ctrv.2007.10.004","article-title":"Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations","volume":"34","author":"Coleman","year":"2008","journal-title":"Cancer Treat Rev"},{"issue":"September (9)","key":"10.1016\/j.steroids.2011.02.034_bib0270","first-page":"862","article-title":"Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations","volume":"11","author":"Holmes","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"August (6)","key":"10.1016\/j.steroids.2011.02.034_bib0275","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1023\/A:1016392129279","article-title":"Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I\/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden)","volume":"13","author":"Lukanova","year":"2002","journal-title":"Cancer Causes Control"},{"issue":"February (2)","key":"10.1016\/j.steroids.2011.02.034_bib0280","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/eje.0.1500161","article-title":"Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women","volume":"150","author":"Lukanova","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"March (2)","key":"10.1016\/j.steroids.2011.02.034_bib0345","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/03014460.2010.507221","article-title":"A cross sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1-2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"38","author":"Crowe","year":"2011","journal-title":"Ann Hum Biol"},{"issue":"November (11)","key":"10.1016\/j.steroids.2011.02.034_bib0290","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/sj.ijo.0803324","article-title":"Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women","volume":"30","author":"Gram","year":"2006","journal-title":"Int J Obes (Lond)"},{"issue":"November (18)","key":"10.1016\/j.steroids.2011.02.034_bib0295","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1001\/jama.288.18.2282","article-title":"Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial","volume":"288","author":"Blackman","year":"2002","journal-title":"JAMA"},{"issue":"June (11)","key":"10.1016\/j.steroids.2011.02.034_bib0300","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jnci\/95.11.779","article-title":"A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers","volume":"95","author":"Decensi","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"April (4)","key":"10.1016\/j.steroids.2011.02.034_bib0305","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0959-8049(98)00428-6","article-title":"Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women","volume":"35","author":"Decensi","year":"1999","journal-title":"Eur J Cancer"},{"issue":"March (3\u20138)","key":"10.1016\/j.steroids.2011.02.034_bib0310","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0960-0760(92)90380-2","article-title":"Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients","volume":"41","author":"Lien","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"April (2)","key":"10.1016\/j.steroids.2011.02.034_bib0315","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10549-009-0662-0","article-title":"MAP1 examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women","volume":"120","author":"Cigler","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"April (4\u20135)","key":"10.1016\/j.steroids.2011.02.034_bib0320","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0960-0760(02)00040-7","article-title":"Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients","volume":"80","author":"Ferrari","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"November\u2013December (4\u20136)","key":"10.1016\/j.steroids.2011.02.034_bib0325","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-0760(97)00120-9","article-title":"The aromatase inhibitor letrozole in advanced breast cancer: effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels","volume":"63","author":"Bajetta","year":"1997","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"June (6)","key":"10.1016\/j.steroids.2011.02.034_bib0330","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1210\/jc.81.6.2216","article-title":"Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer","volume":"81","author":"Frost","year":"1996","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11000742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11000742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T01:18:14Z","timestamp":1560043094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X11000742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0039128X11000742"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2011.02.034","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}